“United Laboratories USLEN” insulin glargin gained experts’ recognition and recommendation

HONG KONG, CHINA – – 14 May 2017 – The United Laboratories International Holdings Limited (“TUL”, the “Company” or the “Group”; HKSE: 3933), participated the “Basal Insulin Clinical Application Summit” in Zhuhai, the PRC, hosted by Chinese Journal of Diabetes Mellitus, together with a launching….


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.